Stamulumab is an experimental drug that inhibits myostatin and can be used to treat muscular dystrophy (MD). Myostatin is a protein that inhibits the growth of muscle tissue. Stamulumab is a recombinant human antibody targetting and inhibiting the activity of myostatin. It is a G1 immunoglobulin antibody that can bind to myostatin and prevent it from binding to its target site, thereby inhibiting the growth-limiting effect of myostatin on muscle tissue.
There are no reviews yet.
Your email address will not be published. Required fields are marked *
In which application did you use the antibody? *
Did it work in your application? *
Your review *
Save my name, email, and website in this browser for the next time I comment.
Send us a message from the form below
Lab / Company
in 2023, NO price increase on ProteoGenix products, to support your discoveries💥